Sens Stock: Eyeing 38 Cents for All-Time Low Buy Opportunity Sens stock, a compelling asset in the realm of healthcare technology, is catching the attention of investors as it approaches the 38-cent mark, representing all-time lows. With the formation of a double bottom and falling wedge pattern, this potential buy opportunity could pave the way for a remarkable...
Sens recent earnings was quite good but the stock has sold off anyway. I have been waiting patiently for this moment as we could be reaching the bottoming phase based on the chart analysis of the bearish shark. What narrative could make it spike up in price? Please do your DD as this is not a financial advice.
SENS Senseonics is waiting for FDA`s approval for the 180-day version of its Eversense CGM system. Eversense can generate as much as $200 million in sales by 2025. HC Wainwright sees a 6usd price target for it. And let`s not forget it`s a meme stock.
Either a Wave 4 WXY pattern or a more general turnaround. Both scenarios are bearish. Note divergences and dropping momentum also. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets going down are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent...
Pulled SENS back up again after a few weeks and see that it's still holding the same fib and trendline levels as it was when we first drew out the fib retracement. It's also now holding the 50DMA consistently as it steadily rises. For some context, this company develops and commercializes continuous glucose monitoring systems for diabetes patients. Senseonics...
First Target is $4. If bullish cup and handle play out then this can shoot to the 1.618 fib at $7. Bullish!
It looks like wave 2 has completed for SENS. They had a conference today march 9th about some things that were already known to us, but they made some things more clear. Quick summary of this conference: - Accuracy of the current device is best in class with a MARD of 8.5% - Medicare National Coverage as of Jan 1, 2021: - Avg "Supply Cost" (I assume this is for...
Sooo, I have bin looking in to #SENS for a while now. And came to the conclusion that this company is sitting on a gold mine. I tried to understand why this company still haven't taken off. Is it because of the short's, or is it a PR issue? I am really lost and would love any idea any one could share with me